1: Sun S, Shi J, Wang X, Huang C, Huang Y, Xu J, Jiang Y, Cao L, Xie T, Wang Y, Huang Z. Atractylon inhibits the tumorigenesis of glioblastoma through SIRT3 signaling. Am J Cancer Res. 2022 May 15;12(5):2310-2322. 2: Li H, Wang F, Zhou Z, Jiang X, Li F, Feng Y, Liu C, Zhang Y, Fan S, Wu X, Huang C. Atractylon, a novel dopamine 2 receptor agonist, ameliorates Parkinsonian like motor dysfunctions in MPTP-induced mice. Neurotoxicology. 2022 Mar;89:121-126. doi: 10.1016/j.neuro.2022.01.010. Epub 2022 Jan 31. 14(4):3704-10. doi: 10.3892/mmr.2016.5713. Epub 2016 Sep 5. 4: Cheng Y, Chen T, Yang X, Xue J, Chen J. Atractylon induces apoptosis and suppresses metastasis in hepatic cancer cells and inhibits growth in vivo. Cancer Manag Res. 2019 Jun 28;11:5883-5894. doi: 10.2147/CMAR.S194795.
合成参考文献
参考文献:10.1248/bpb.19.577 摘要:MIZUKAMI H, SHIMIZU R, KOHDA H, KOHJYOUMA M, KAWANISHI F, HIRAOKA N. Restriction fragment length polymorphisms of medicinal plants and crude drugs. IV. Restriction Fragment Length Polymorphisms of rDNA and Variation of Essential Oil Composition in Atractylodes Plants. Biological & Pharmaceutical Bulletin. 1996;19(4):577–80. doi: 10.1248/bpb.19.577. 参考文献:10.1007/s002040050323 摘要:Hwang JM, Tseng TH, Hsieh YS, Chou FP, Wang CJ, Chu CY. Inhibitory effect of atractylon on tert-butyl hydroperoxide induced DNA damage and hepatic toxicity in rat hepatocytes. Arch Toxicol. 1996;70(10):640–4. doi: 10.1007/s002040050323. 参考文献:10.1038/s41392-021-00553-z 摘要:Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy. 2021 Apr 28;6(1):162. doi: 10.1038/s41392-021-00553-z.